Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Elevated Triglyceride Levels and Later Type 2 Diabetes

This study has been completed.
Sponsor:
Information provided by:
University of Tromso
ClinicalTrials.gov Identifier:
NCT01182935
First received: August 11, 2010
Last updated: July 19, 2011
Last verified: July 2011

August 11, 2010
July 19, 2011
April 2010
September 2010   (final data collection date for primary outcome measure)
Number of subjects with type 2 diabetes diagnosed with oral glucose tolerance test (OGTT) [ Time Frame: At study enrollment in 2010 ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01182935 on ClinicalTrials.gov Archive Site
The relation between serum 25(OH)D levels and blood glucose levels at OGTT [ Time Frame: At study enrollment in 2010 ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Elevated Triglyceride Levels and Later Type 2 Diabetes
Elevated Triglyceride Levels and Later Type 2 Diabetes

Subjects with elevated serum triglycerides in the 4th Tromso study in 1994/1995 were re-examined with an oral glucose tolerance test to see predictive value of triglycerides regarding development of type 2 diabetes

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples Without DNA
Description:

serum

Non-Probability Sample

participants in the 4 Tromsø study 1994 and with elevated serum triglyceride levels

Type 2 Diabetes
Not Provided
participants in the 4th Tromsø study
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
3509
November 2010
September 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • participants in the 4 Tromso study 1994 and with elevated serum triglyceride levels

Exclusion Criteria:

  • type 2 diabetes
Both
20 Years to 80 Years
Yes
Contact information is only displayed when the study is recruiting subjects
Norway
 
NCT01182935
UIT-ENDO-2010-3
No
Rolf Jorde, Univesity of Tromsø
University of Tromso
Not Provided
Principal Investigator: rolf jorde, md University of Tromso
University of Tromso
July 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP